NIH Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Patients
Today's Clinical Lab
What role might beta-HPV play in skin cancer among patients with weakened T-cell immunity?
Skin Cancer
Biomarker Could Better Predict Response to Immunotherapy in Black Patients with Skin Cancer
University Hospital Bonn
The new biomarker could predict who may be resistant or develop resistance to melanoma treatment
FDA Approves First Immunotherapy for Metastatic Skin Cancer
U.S. Food and Drug Administration
The FDA granted the approval of Amtagvi to Iovance Biotherapeutics Inc.
Metastasis-Guiding Marker Discovered in Skin Cancer Cells
Center for Genomic Regulation
Targeting LDL levels and specific proteins in tumor cells may help monitor and prevent them from metastasizing
NIH Releases Annual Report to the Nation
National Institutes of Health
Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer
Phase II Clinical Trial Generates Promising Results
Wiley
Findings support the use of immune checkpoint blockers as standard therapies in advanced skin cancer
Biomarkers That Predict Response to Immune Checkpoint Inhibitor Therapy
The Wistar Institute
New research finds biological processes that improve prediction of therapeutic performance
First Melanoma Test to Reliably Predict Risk of Cancer Spread
Newcastle University
New test developed as mechanism of skin cancer growth understood
New Insights on How Interleukin-33 Contributes to Skin and Pancreatic Cancers
Massachusetts General Hospital
The results suggest that inhibiting IL-33 in cancer-prone cells may help prevent cancers associated with inflammation
Immunotherapy before Surgery Could Help Beat Aggressive Skin Cancer
Johns Hopkins Medicine
Immune 'checkpoint' inhibitor treatment found useful against Merkel cell carcinoma in multicenter clinical trial